We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.
Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.
Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.
The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.
A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
MSF first worked in Algeria in 1980 and closed its projects in 2016.
MSF began working in Algeria in 1980 after an earthquake struck the country and provided assistance in different capacities until 2016.
We ran specialised projects on training for mental health counselling and HIV treatment for at-risk groups including migrants, intravenous drug users and sex workers. We also provided emergency response during disasters, such as the 2001 flood in the capital Algiers and after an earthquake in 2003. We closed our last project, an HIV programme, in Algeria in 2016.
MSF first worked in Algeria in
Access to medicines
2,500 flowers are placed in front of Pfizer’s HQ, representing number of children who die of pneumonia each day.
Press Release27 Apr 2016
Will they kill us here in Europe?
Voices from the Field13 Apr 2016
High vaccine prices hamper immunisation efforts in Africa, but are missing from agenda of key vaccination conference
Press Release24 Feb 2016
War and conflict
Support to health facilities in the Middle East and North Africa
Project Update23 Mar 2011
Body set up to seek drugs for the poor
Project Update4 Jul 2003
Access to Healthcare
NGOs slam G8 poverty pledges
Project Update3 Jun 2003
MSF sends in more staff to assist victims of earthquake